Some additional info was provided as follows:
Granted under the Issuer's 2005 Equity Incentive Plan.
25% of such shares vest one year from the date of grant and 2.0833% vests each month thereafter, provided that Reporting Person continues to be employed by the Issuer.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever SciClone Pharmaceuticals makes a similar move, sign up!